| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |